Recombinant Human ANAPC13 Protein，His

ANAPC13, a crucial component of the Anaphase-Promoting Complex/Cyclosome (APC/C), plays a vital role in the regulation of the cell cycle by mediating the ubiquitination and subsequent degradation of cell cycle proteins. The APC/C is a multi-subunit E3 ubiquitin ligase that orchestrates the transition from metaphase to anaphase by targeting key regulatory proteins, such as cyclins and other cell cycle inhibitors, for proteasomal degradation. This process ensures the proper timing of chromosome segregation and the overall fidelity of cell division. Dysregulation of APC/C activity, particularly involving subunits like ANAPC13, has been implicated in various cancers, as aberrant cell cycle progression can lead to uncontrolled cellular proliferation. Furthermore, understanding the structure and function of ANAPC13 is critical for elucidating the mechanisms of APC/C-mediated protein degradation and its broader implications in cancer biology and therapeutics. Recent research has focused on the biochemistry of ANAPC13, including its interactions with other APC/C subunits and substrates, as well as its post-translational modifications. By studying recombinant ANAPC13 proteins in vitro, researchers aim to reveal insights into the regulatory mechanisms of APC/C, which may pave the way for the development of targeted cancer therapies that could restore normal cell cycle control or exploit vulnerabilities in cancer cells resulting from APC/C dysfunction. The integration of structural biology techniques, such as X-ray crystallography and cryo-electron microscopy, with functional assays will contribute to a comprehensive understanding of ANAPC13's role within the APC/C complex. This research is pivotal in advancing our knowledge of cell cycle regulation and its implications in oncogenesis.